Results 71 to 80 of about 44,755 (204)

A new drug for an old concept: aptamer to von Willebrand factor for prevention of arterial and microvascular thrombosis

Haematologica, 2020
Agnès Veyradier
doaj   +1 more source

Von Willebrand hastalığı’nda oral cerrahi yaklaşım: olgu sunumu

Cumhuriyet Dental Journal, 2011
Von Willebrand Disease (VWD) is a hereditary coagulation disorder characterized by a deficient or abnormal plasma protein known as the von Willebrand factor (vWF).
Ahmet Arslan, Ediz Deniz
doaj  

Management of von Willebrand disease type 3 during pregnancy - 2 cases reports. [PDF]

, 2013
BACKGROUND: von Willebrand disease type 3, is an extremely rare condition. It can be severe and potentially life-threatening, particularly in pregnant women during labor and subsequently during early puerperium.
Inocêncio, G., Azevedo, S., Buchner, C, Braga, A.   +3 more
core  

Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease

, 1992
Desmopressin (1-deamino-8-D-arginine vasopressin) is a synthetic analogue of the antidiuretic hormone L-arginine vasopressin. Because it can raise circulating levels of factor VIII and von Willebrand factor, desmopressin is used for nontransfusional ...
M. Cattaneo, P. M. Mannucci
core  

von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report

TH Open
The development of inhibitors to von Willebrand factor (VWF) is a rare but potentially serious complication of VWF replacement therapy in patients with von Willebrand disease (VWD).
Claudia Djambas Khayat, Anna Pavlova, Sylvia Werner, Sigurd Knaub, Robert F. Sidonio   +4 more
doaj   +1 more source

Managing oral surgery in von willebrand disease: lessons from a challenging case

Von Willebrand disease is a rare inherited bleeding disorder characterized by deficient or defective von Willebrand factor, crucial for platelet adhesion and aggregation.
Ascani, Giuliano, Romano, Michele, Azzuni, Francesca, Di Nobile, Erminia, Benfatto, Silvia, Ranalli, Paola   +5 more
core   +1 more source

A Novel Use Of Thromboelastography In Type 2b Von Willebrand Disease

, 2013
[No abstract available]356e11e14Hampshire, D.J., Goodeve, A.C., The international society on thrombosis and haematosis von Willebrand disease database: an update (2011) Semin Thromb Hemost, 37, pp. 470-479Von Willebrand disease mutation database, , http:/
Ozelo M.C., Othman M., Angelillo-Scherrer A., Toukh, M., Angelillo-Scherrer, A., Othman, M., Toukh M., Ozelo, M.C.   +7 more
core   +1 more source

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A

Therapeutics and Clinical Risk Management, 2016
Giancarlo Castaman, Silvia Linari Department of Oncology, Center for Bleeding Disorders, Careggi University Hospital, Florence, ItalyAbstract: Several plasma-derived intermediate and high-purity concentrates containing von Willebrand factor (VWF) and ...
Castaman G, Linari S
doaj  

Diagnosing von Willebrand disease

, 2019
Von Willebrand disease (VWD) is an inherited bleeding disorder with abnormal primary haemostasis due to defects in, or decreased concentration of the glycoprotein von Willebrand factor.
Funding, Eva, Vojdeman, Fie Juhl, Philips, Malou, Gøtze, Jens Peter   +3 more
core  

Von Willebrand Disease in the Netherlands [PDF]

, 2015
Von Willebrand Disease (VWD) is the most common inherited bleeding disorder resulting in mucocutaneous bleeding, like epistaxis, oral cavity bleeding and menorrhagia. VWD is caused by reduced or dysfunctional von Willebrand Factor (VWF).
Sanders, Y.V. (Yvonne)
core